2012
DOI: 10.1586/eri.12.100
|View full text |Cite
|
Sign up to set email alerts
|

Toxoplasmahistone acetylation remodelers as novel drug targets

Abstract: Toxoplasma gondii is a leading cause of neurological birth defects and a serious opportunistic pathogen. The authors and others have found that Toxoplasma uses a unique nucleosome composition supporting a fine gene regulation together with other factors. Post-translational modifications in histones facilitate the establishment of a global chromatin environment and orchestrate DNA-related biological processes. Histone acetylation is one of the most prominent post-translational modifications influencing gene exp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
46
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 110 publications
0
46
0
Order By: Relevance
“…Consistent with the immunostimulant effect of NSO (Fararh et al 2004), DNA fragmentation and activation of the mitochondrial-signaling proapoptotic pathway may be another modes of action that were previously reported by Salim et al (2013) in their trials for treating cancer cells with NSO. Moreover, NSO can inhibit DNA synthesis by inhibiting histone deacetylase (HDAC) enzyme in cancer cells (Vanagas et al 2012;Zubair et al 2013), a mode of action that needs further verification with respect to Toxoplasma.…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with the immunostimulant effect of NSO (Fararh et al 2004), DNA fragmentation and activation of the mitochondrial-signaling proapoptotic pathway may be another modes of action that were previously reported by Salim et al (2013) in their trials for treating cancer cells with NSO. Moreover, NSO can inhibit DNA synthesis by inhibiting histone deacetylase (HDAC) enzyme in cancer cells (Vanagas et al 2012;Zubair et al 2013), a mode of action that needs further verification with respect to Toxoplasma.…”
Section: Discussionmentioning
confidence: 99%
“…FR23522 and its derivatives also display potent activity against Toxoplasma by targeting a KDAC called TgHDAC3 (4,5). In contrast, there are no reports to date of a Toxoplasma KAT inhibitor despite genetic studies showing that KATs are essential for parasite viability (6)(7)(8)(9)(10)(11)(12)(13). The putative KAT inhibitor MC1626 has inhibitory activity against tachyzoites but most likely through an off-target effect (14).…”
mentioning
confidence: 99%
“…As seen for higher eukaryotic cells, the Toxoplasma acetylome contains proteins residing in all cellular compartments, including the single parasite mitochondrion. Lysine acetylation is critical for parasite replication and survival, and enzymes modulating lysine acetylation have been validated as drug targets (12)(13)(14). We have characterized a number of KATs in the parasite, noting that TgGCN5 family KATs are exclusively nuclear and TgMYST family KATs are predominantly cytosolic (15)(16)(17).…”
mentioning
confidence: 99%